This is an interesting article from Forbes. In the wake of the Sovaldi launch, the most successful drug launch in history, they pose the question: has healthcare embraced a 'hit and run' pricing strategy, and is this bad news for society?
http://www.forbes.com/sites/bernardmunos/2014/04/16/has-healthcare-embraced-a-hit-and-run-strategy/